Valérie Clerc is the new Secretary General of SAMS
In June 2017, the Executive Board appointed Valérie Clerc General Secretary of SAMS. On 1 November, she is taking over from Hermann Amstad, who will leave SAMS at the end of the month after 18 years of cooperation.
The press release dated July 4, 2017 contains more information on Valérie Clerc’s career. Contact details of all SAMS employees can be found on our website under «Portrait».
Press release (German): Valérie Clerc wird Generalsekretärin der SAMW PDF
Strengthening biomedical research for the benefit of European citizens
Europe is facing a number of major healthcare challenges, particularly as a result of an ageing population. To master these challenges, joint research activites in biomedical and clinical research across the European Union are needed. In a recent position paper, FEAM postulates five key points to overcome current gaps. As a member of FEAM, the SAMS supports these efforts.
The Federation of European Academies of Medicine (FEAM) and the Alliance for Biomedical Research in Europe have united to strengthen biomedical research in Europe. In their recently published position paper they call upon the EU, that the support of biomedical research has to be a key priority for the next EU Framework Programme for Research and Innovation. To learn more, download the position paper or visit the FEAM website.
Strengthening biomedical research for the benefit of European citizens PDF
Weighing of interests for proposed animal experiments
Researchers submitting an application to conduct an animal experiment in Switzerland are required to consider ethical as well as scientific aspects. The ethical evaluation takes the form of a «weighing of interests». A new guidance for applicants should help to carry out the procedure correctly.
The brochure (Englisch/French/German) explains the principle of the weighing of interests for proposed animal experiments and contains a step-by-step guide. Printed copies are available free of charge – also in bulk – from: email@example.com.
Weighing of interests for proposed animal experiments – Guidance for applicants PDF
Steps #2: Getting to know the SPHN Partners
SAMS highlights specific topics concerning the Swiss Personalized Health Network (SPHN) in its newsletter «Steps». The current issue presents relevant partners and their activities.
Steps #2 is dedicated to the actors who play – besides universities and university hospitals – a central role in the research in personalized health in Switzerland. Find out who is integrated into the SPHN initiative and learn about their role. Find more publications on the SPHN website.
SPHN Newsletter «Steps #2»: SPHN Partners PDF
Swiss Personalized Health Network: First call for proposals
The Swiss Personalized Health Network (SPHN) is launching its first call for proposals aimed at the development of a national interoperable research infrastructure ecosystem for competitive personalized health research. The submission deadline is on Friday, September 15, 2017.
In order to make the best use of the available resources, the SPHN call for proposals is coordinated with the ETH-Domain Strategic Focus Area in Personalized Health and Related Technologies. For further information see the «SPHN Call for Proposals 2017» or visit the SPHN-Website.
SPHN Call for Proposals 2017 PDF
Differences of sex development: Opinion of the Central Ethics Committee
In 2016, two articles were published in the «Schweizerische Ärztezeitung» concerning medical interventions relating to sex assignment. The Central Ethical Commitee (CEC) of SAMS was called on to ensure, by issuing ethical recommendations, that no unnecessary medical or surgical treatments are carried out during infancy or childhood.
In the present situation, the CEC does not consider it appropriate to issue comprehensive medical-ethical guidelines on this topic. However, after consulting both the Swiss Medical Association and the Federal Office of Justice and seeking the views of experts, it offers the following recommendations.
«Differences of sex development»: Opinion of the Central Ethics Committee of the SAMS / 16.12.2016 PDF
Daniel Scheidegger is the incoming president of SAMS
Daniel Scheidegger, from Basel, will assume presidency of the Swiss Academy of Medical Sciences on 1 November 2016. He has been a member of the Academy since 2005 and has been involved in numerous projects. Daniel Scheidegger is taking over from Peter Meier-Abt, who has been President since May 2011.
From 1988 to 2013, he was the Head of the Department of Anaesthesia and Intensive Care at the University Hospital of Basel and a Professor of Anaesthesia and Resuscitation at the University of Basel. He is well-known among many players in the healthcare system because of his involvement in national committees such as Member and President of the specialist body for highly specialised medicine of the CMPH or Member of the Swiss Science and Innovation Council SSIC. The press release contains further information about his professional background.
Press release: Daniel Scheidegger is the incoming president of SAMS (26.10.2016) PDF
Improve the reproducibility of biomedical research
Togther with 45 members of the InterAcademy Partnership for Health the SAMS commits to taking action to address issues of reproducibility in a Statement: «A Call to Action to Improve the Reproducibility of Biomedical Research».
The Statement outlines the causes of irreproducible results and recognises the leading role the academies can play in addressing this challenge in their own countries and worldwide.
A call for action: Reproducibility of biomedical research PDF